ITGB3 promotes cisplatin resistance in osteosarcoma tumors.
Cancer medicine
Li Q, Chen G, Jiang H, Dai H, Li D, Zhu K, Zhang K, Shen H, Xu H, Li S.
Publication Overview
Key findings, Countstar context, and access to the original paper.
2023
Cancer Research
No items found.
Key Finding
The study's will contribute to a better understanding of the function and mechanism of ITGB3 in osteosarcoma cisplatin resistance and provide a novel therapeutic target to decrease cisplatin resistance and tumor recurrence in osteosarcoma patients.
Countstar Connection
Researchers relied on Countstar (model not specified) for cell-count measurements in the study's cell samples during cell-culture monitoring.
